reglab/statecodes huggingface dataset:
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter F - SEXUALLY TRANSMITTED DISEASES INCLUDING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) › Section 97.137 - Exposure of Health-Care Personnel to Acquired Immune Deficiency Syndrome (AIDS), Human Immunodeficiency Virus (HIV) Infection

Current through Reg. 49, No. 28; July 12, 2024
(a) Health-care personnel are at risk of
				  exposure to HIV or AIDS if the personnel are in contact with blood or other
				  body fluids (amniotic fluid, pericardial fluid, peritoneal fluid, pleural
				  fluid, synovial fluid, cerebrospinal fluid, semen, and vaginal secretions) or
				  any body fluid visibly contaminated with blood through percutaneous inoculation
				  or contact with an open wound, nonintact skin or mucous membrane during the
				  performance of normal job duties.
(b) Health-care personnel are at risk of
				  exposure to HIV or AIDS during a medical procedure if the personnel have their
				  mucous membranes or skin in contact with any body fluid or tissue (other than
				  patient's intact skin) and if the procedure to be performed is an invasive
				  procedure that involves surgical entry into tissues, cavities, or organs or the
				  repair of major traumatic injuries, including angiographic, bronchoscopic,
				  endoscopic, and obstetrical procedures.
(c) Health-care personnel should follow the
				  most current exposure and risk guidance provided by the federal Centers for
				  Disease Control and Prevention.
(d)
				  Publications related to the prevention of HIV or AIDS are available upon
				  request from: HIV/STD Comprehensive Services Branch, Department of State Health
				  Services, 1100 West 49th Street, Austin, Texas 78756-3199.
(e) Texas Health and Safety Code,
				  §§
										85.201 -
				  85.203
				  contain requirements and information for health care personnel regarding
				  infection control standards and related issues under this section. Also, see
				  §
										96.202 of
				  this title (relating to Exposure Control Plan).
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter F - SEXUALLY TRANSMITTED DISEASES INCLUDING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) › Section 97.139 - Fee for Providing Written Notice of a Positive Human Immunodeficiency Virus (HIV)-Related Test Result to an Applicant for Insurance

Current through Reg. 49, No. 28; July 12, 2024
An applicant for insurance must be given written notice of
					 a positive HIV-related test result by a physician designated by the applicant,
					 or in the absence of that designation, by the department. When the department
					 is requested to make this notification:
(1) the form designated by the department for
				  this purpose must be used. Copies of the form and other information concerning
				  notification by the department may be requested from: Texas Department of State
				  Health Services, Epidemiology and Surveillance Branch, Mail Code 1873, P.O. Box
				  149347, Austin, Texas 78714-9347; and
(2) the insurer shall pay the department a
				  fee of $25 to cover the cost of the department providing the written notice to
				  the applicant for insurance, pursuant to Texas Insurance Code, §
										545.055.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter F - SEXUALLY TRANSMITTED DISEASES INCLUDING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) › Section 97.140 - Counseling and Testing for State Employees Exposed to Human Immunodeficiency Virus (HIV) Infection on the Job

Current through Reg. 49, No. 28; July 12, 2024
(a)
				  Purpose. The purpose of this section is to implement the provisions of the
				  Communicable Disease Prevention and Control Act, Texas Health and Safety Code,
				  §
										85.116,
				  which requires the Department of State Health Services (department) to adopt
				  rules to implement the Act.
(b)
				  Counseling and testing.
(1) The counseling
				  for state employees exposed to HIV on the job should be performed in accordance
				  with the most current guidelines developed by the department. Copies are
				  available for review in the HIV/STD Comprehensive Services Branch, Department
				  of State Health Services, 1100 West 49th Street, Austin, Texas 78756-3199.
				  Copies also are available on request.
(2) A state employee who may have been
				  exposed to HIV while engaged in activities within the course and scope of state
				  employment may not be required to be tested for HIV.
(3) HIV counseling and testing will be
				  performed on the state employee, when requested by that employee, at the
				  expense of the state agency if:
(A) the
				  employee documents to the agency's satisfaction that he or she may have been
				  exposed to HIV while engaged in activities within the course and scope of state
				  employment; and
(B) the exposure
				  was a needlestick or other penetrating puncture of the skin with a used needle
				  or other contaminated item; or either a splatter or aerosol into the eye, nose,
				  or mouth or any significant contamination of an open wound or non-intact skin
				  with blood or body fluids known to transmit HIV.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter F - SEXUALLY TRANSMITTED DISEASES INCLUDING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) › Section 97.141 - Fee to Cover the Cost of Providing the Human Immunodeficiency Virus (HIV) and Hepatitis C Protocol-Based Counseling Course

Current through Reg. 49, No. 28; July 12, 2024
(a) Purpose. The purpose of this section is
				  to implement the provisions of the Health and Safety Code, §
										85.087 and
				  §
										94.004,
				  requiring the Department of State Health Services (department) to develop and
				  offer a training course for persons providing HIV and/or hepatitis C
				  counseling, and authorizes the department to charge a fee for the
				  course.
(b) Content. The training
				  course includes information relating to risk reduction and the special needs of
				  persons with positive test results for the diseases. General information on
				  these diseases is sent to participants prior to the actual course.
(c) Fee.
(1) The course fee will be $300 for each
				  participant, except that no fee is required from employees of an entity that
				  receives state or federal funds for HIV or Hepatitis C counseling and testing
				  through a current contract with the department. The HIV/STD Comprehensive
				  Services Branch may waive the fee, at its sole discretion, according to its
				  written internal procedures regarding compelling public health need.
(2) Fees shall be made payable to the
				  Department of State Health Services. All fees are non-refundable and must be
				  received by the department prior to participation in the course. The accepted
				  forms of payment are cashiers check or money order. No other form of payment
				  will be accepted.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter F - SEXUALLY TRANSMITTED DISEASES INCLUDING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) › Section 97.142 - Model Health Education Program/Resource Guide for HIV/AIDS Education of School-Age Children

Current through Reg. 49, No. 28; July 12, 2024
The documents referenced in Texas Health and Safety Code,
					 §§
										85.004 -
					 85.007
					 and §§163.001 - 163.002 can be obtained from the Health Promotion
					 Unit, Department of State Health Services, 1100 West 49th Street, Austin, Texas
					 78756-3199.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter F - SEXUALLY TRANSMITTED DISEASES INCLUDING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) › Section 97.143 - Model HIV/AIDS Workplace Guidelines

Current through Reg. 49, No. 28; July 12, 2024
(a)
				  The Department of State Health Services has prepared and maintains model
				  workplace guidelines consistent with current public health information and with
				  state and federal laws and regulations as required by the Texas Health and
				  Safety Code, §
										85.012.
(b) Interested individuals or entities may
				  review the guidelines or obtain copies by contacting the HIV/STD Comprehensive
				  Services Branch, Department of State Health Services, 1100 West 49th Street,
				  Austin, Texas 78756-3199.
(c)
				  Employers are encouraged to adopt HIV-related workplace guidelines that
				  incorporate, at a minimum, the department guidelines referenced in this
				  section.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter F - SEXUALLY TRANSMITTED DISEASES INCLUDING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) › Section 97.144 - Model Policies for the Handling, Care, and Treatment of HIV/AIDS-Infected Persons in the Custody of the Texas Department of Criminal Justice, Local Law Enforcement Agencies, Municipal and County Correctional Facilities, and District Probation Departments

Current through Reg. 49, No. 28; July 12, 2024
(a) The
				  Department of State Health Services has prepared the model policies concerning
				  persons in custody required by the Texas Health and Safety Code, §
										85.141.
(b) The model policies are available for
				  review in the HIV/STD Comprehensive Services Branch, Department of State Health
				  Services, 1100 West 49th Street, Austin, Texas 78756-3199. Copies are available
				  upon request.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter F - SEXUALLY TRANSMITTED DISEASES INCLUDING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) › Section 97.145 - Anonymous and Confidential HIV Testing

Current through Reg. 49, No. 28; July 12, 2024
(a) State-funded primary health, women's
				  reproductive health, and sexually transmitted disease clinics shall provide
				  voluntary and affordable counseling and testing programs for HIV infection, or
				  provide referrals to such programs. These entities shall offer both anonymous
				  and confidential testing for HIV infection or provide referrals for anonymous
				  and confidential testing.
(b) All
				  HIV testing sites funded by the Department of State Health Services shall offer
				  confidential and anonymous HIV testing on site.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter F - SEXUALLY TRANSMITTED DISEASES INCLUDING ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) › Section 97.146 - Confidentiality of Test Results

Current through Reg. 49, No. 28; July 12, 2024
A test result under this subchapter is confidential. A
					 person that possesses or has knowledge of a test result may not release or
					 disclose the test result or allow the test result to become known except as
					 provided by Health and Safety Code, §
										81.103
					 and other applicable state and federal law. Under Texas Health and Safety Code,
					 §
										81.103(j),
					 a person commits an offense if, with criminal negligence and in violation of
					 this section, the person releases or discloses a test result or other
					 information or allows a test result or other information to become known. An
					 offense under this section is a Class A misdemeanor.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter G - VACCINATION STAMPS › Section 97.151 - Purpose and Scope

Current through Reg. 49, No. 28; July 12, 2024
The U.S. Public Health Service has designated the
					 Department of State Health Services as the governmental entity in the State of
					 Texas that is responsible for determining which physicians in the state are
					 authorized to administer yellow fever vaccine for persons who travel outside
					 the United States. The department provides this authorization by issuing
					 Uniform Stamps to designated physicians. These sections cover the criteria by
					 which the department issues the Uniform Stamp and the criteria for designating
					 and operating a Vaccination Center.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter G - VACCINATION STAMPS › Section 97.152 - Definitions

Current through Reg. 49, No. 28; July 12, 2024
The following words and terms, when used in these sections,
					 shall have the following meanings, unless the context clearly indicates
					 otherwise:
(1) Department--The
				  Department of State Health Services, 1100 West 49th Street, Austin, Texas
				  78756.
(2) Unit --The Immunization
				  Unit, Infectious Disease Prevention Section, Department of State Health
				  Services.
(3) Physician--A
				  physician (medical doctor or doctor of osteopathic medicine) licensed to
				  practice medicine in the State of Texas.
(4) Vaccination Center--The location where a
				  physician is authorized to administer yellow fever vaccine.
(5) Uniform Stamp--A stamp issued by the unit
				  to a physician for use in validating certificates of yellow fever vaccination
				  for persons who travel outside the United States.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter G - VACCINATION STAMPS › Section 97.153 - Criteria for Issuing Uniform Stamps to Physicians

Current through Reg. 49, No. 28; July 12, 2024
Uniform Stamps may be issued to physicians holding a
					 current Texas medical license, for use only at the specific Vaccination Center
					 designated on the Uniform Stamp Application Form. If a physician practices at
					 more than one Vaccination Center, a separate Uniform Stamp Application Form and
					 Uniform Stamp are required for each Vaccination Center.
(1) Physicians may apply for the Uniform
				  Stamp by sending the Uniform Stamp Application Form to the unit. The Uniform
				  Stamp Application Form may be obtained from the unit or online at
http://www.dshs.texas.gov/immunize/
.
(2) Physicians who move the location of their
				  practice within the same county must report a change of address in writing to
				  the unit. Physicians who move their practice to another county must submit a
				  Uniform Stamp Replacement Form and a Uniform Stamp replacement fee.
(3) Physicians are authorized to use the
				  Uniform Stamp solely for the purpose of validating administration of yellow
				  fever vaccine on vaccination certificates issued only at the approved
				  Vaccination Center indicated on the Uniform Stamp Application Form.
(4) Physicians are authorized to use only the
				  Uniform Stamp assigned to them. Uniform Stamps may not be assigned, loaned, or
				  given to another person or physician except those working under supervision of
				  the physician holding the stamp. The physician will at all times be responsible
				  for the Uniform Stamp.
(5) A
				  physician shall report immediately to the unit any loss or theft of the Uniform
				  Stamp.
(6) Physicians are
				  encouraged to report adverse events potentially caused by yellow fever
				  vaccination to the CDC/FDA Vaccine Adverse Events Reporting System (VAERS
				  http://www.vaers.hhs.gov/).
(7)
				  U.S. Public Health Services (PHS) requirements. The PHS requirements are found,
				  as follows:
(A) Code of Federal Regulations,
				  Title 42-Public Health, Part 71-Foreign Quarantine, §71.3, Designation of
				  Yellow Fever Vaccination Centers; Validation Stamps; and
(B) PHS publications entitled, Division of
				  Quarantine Circular No. 106; Advisory Memorandum No. 66; and Advisory
				  Memorandum No. 72.
(C) The
				  department adopts the PHS requirements listed in subparagraphs (A) and (B) of
				  this paragraph by reference. Copies of the requirements are available upon
				  request from the Immunization Unit, Department of State Health Services, P.O.
				  Box 149347, Austin, Texas 78714-9347 or (800) 252-9152.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter G - VACCINATION STAMPS › Section 97.154 - Criteria for Operating as a Vaccination Center

Current through Reg. 49, No. 28; July 12, 2024
Designation as a Vaccination Center is made upon completion
					 and approval of a Uniform Stamp Application Form.
(1) A physician shall use the Uniform Stamp
				  only at the Vaccination Center where the yellow fever vaccine is delivered and
				  the vaccine may not be redistributed. The physician to whom the Uniform Stamp
				  has been issued is not authorized to administer yellow fever vaccine on board
				  ship or aircraft.
(2) Physicians
				  shall administer and store yellow fever vaccine in accordance with the vaccine
				  manufacturers' recommendations for safe and effective use of yellow fever
				  vaccine.
(3) Each physician holding
				  a Uniform Stamp shall establish the need for continuing possession of the stamp
				  by completing and returning the Uniform Stamp Renewal Form along with the
				  annual renewal fee. The Uniform Stamp Renewal Form is available from the unit
				  or online at
http://www.dshs.texas.gov/immunize/
.
(A) If the Uniform Stamp Renewal Form is not
				  received by the unit by the deadline stated on the Uniform Stamp Renewal Form,
				  designation as an authorized Vaccination Center may be removed and the
				  physician will be required to return the Uniform Stamp.
(B) If the physician no longer wishes to
				  retain the Uniform Stamp, the stamp must be returned to the unit.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter G - VACCINATION STAMPS › Section 97.155 - Format of the Uniform Stamp

Current through Reg. 49, No. 28; July 12, 2024
The format of the Uniform Stamps will be according to
					 federal guidelines in the Division of Quarantine Circular No. 106, which is
					 adopted by reference in §
										97.153
					 of this title (relating to Criteria for Issuing Uniform Stamps to
					 Physicians).
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter G - VACCINATION STAMPS › Section 97.156 - Denial, Suspension, or Revocation of a Uniform Stamp

Current through Reg. 49, No. 28; July 12, 2024
(a) The unit may deny a Uniform Stamp
				  Application Form for a Uniform Stamp or suspend or revoke an existing stamp or
				  not renew a stamp if the applicant or holder fails to comply with the
				  requirements of this subchapter (relating to Vaccination Stamps). The applicant
				  or holder has the opportunity to request a hearing on any of these actions in
				  accordance with department fair hearing rules, §§
										1.51-
				  1.55 of this
				  title (relating to Fair Hearing Procedures).
(b) The unit will not suspend or revoke a
				  Uniform Stamp without a prior hearing, except if the unit determines that
				  immediate suspension or revocation is necessary because of imminent threat to
				  public health.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.171 - Purpose

Current through Reg. 49, No. 28; July 12, 2024
These sections establish regulations for screening and
					 treatment for tuberculosis and latent tuberculosis infection of employees,
					 volunteers and inmates or detainees in county jails and other correctional
					 facilities that have bed capacities of 100 or more, jails that house inmates
					 transferred from a county that has a jail with a capacity of 100 or more beds,
					 and jails that house inmates from another state or country.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.172 - Scope

Current through Reg. 49, No. 28; July 12, 2024
These sections cover the screening process (tests,
					 administration of tests, interpretation of tests, vaccination, x-rays,
					 frequency of screening tests, and exemption from testing); professional
					 examinations, criteria for repeat testing and treatment of latent tuberculosis
					 infection; diagnostic evaluations, isolation and disease prevention; treatment;
					 reporting requirements; and recordkeeping for all employees, volunteers, and
					 inmates of county jails and other correctional facilities in
					 Texas.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.173 - Screening

Current through Reg. 49, No. 28; July 12, 2024
Screening for tuberculosis (TB) in institutional settings
					 usually involves testing for latent tuberculosis infection (LTBI) and
					 additional evaluation of those who are infected. In some correctional
					 facilities, it may be more practical to screen with chest x-rays to identify
					 individuals with lung abnormalities suggestive of pulmonary tuberculosis. While
					 the chest x-ray method is more expensive, it can be an acceptable technique to
					 identify and segregate tuberculosis suspects; however, use of the chest x-ray
					 screening method on intake is to be followed by testing for latent TB infection
					 within 14 days.
(1) Tuberculin skin
				  test.
(A) The tuberculin skin test utilizing
				  purified protein derivative (PPD) is the standard method of identifying persons
				  infected with
Mycobacterium tuberculosis,
the causative agent
				  of TB. The intradermal Mantoux PPD test, not a multiple puncture test, shall be
				  used to detect latent tuberculosis infection.
(B) The Mantoux PPD test is the only type of
				  testing material that is supplied by the Texas Department of Health
				  (department).
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.174 - Scope of Professional Examinations/Evaluation

Current through Reg. 49, No. 28; July 12, 2024
(a) Examination for active tuberculosis (TB).
(1) Persons with positive tuberculin skin
				  tests or with skin-test conversions on repeat testing or after exposure shall
				  be clinically evaluated for active TB. Persons with symptoms suggestive of TB
				  shall be evaluated regardless of skin-test results.
(2) If TB is diagnosed, appropriate therapy
				  shall be instituted according to accepted medical practice.
(A) Persons diagnosed with active TB shall be
				  offered counseling and human immunodeficiency virus (HIV)-antibody
				  testing.
(B) The need for
				  counseling and HIV testing should be stressed in persons diagnosed with active
				  TB.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.175 - Diagnostic Evaluations

Current through Reg. 49, No. 28; July 12, 2024
(a) The
				  following flow chart shows the steps used in the diagnostic evaluation process.
Attached
					 Graphic
(b)
				  Bacteriologic examinations of specimens.
(1)
				  Persons with TB symptoms and/or chest x-ray suggestive of active TB will need
				  bacteriologic evaluation of sputum or another specimen for "acid fast bacilli"
				  (AFB) smear and culture.
(2)
				  Initially, a series of three sputum specimens shall be collected and examined
				  by smear and culture. At least two of the sputum specimens shall be collected
				  early in the morning of successive days. Supervision shall be used to ensure
				  proper specimen collection.
(3) The
				  Texas Department of Health will supply appropriate sputum collection materials
				  and perform the smear and culture tests.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.176 - Treatment

Current through Reg. 49, No. 28; July 12, 2024
(a) Treatment of
				  latent TB infection, no disease.
(1)
				  Treatment of latent TB infection is the administration of medicine to which a
				  person's infecting organism is presumed to be susceptible. Treatment of latent
				  TB infection substantially reduces the risk of developing active tuberculosis
				  (TB) in infected persons.
(2) All
				  persons who have latent TB infection with no symptoms suggestive of TB disease
				  or radiographic findings suggestive of TB disease shall be considered for
				  treatment of latent TB infection in accordance with current recommendations of
				  the Centers for Disease Control and Prevention and of the department.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.177 - Prevention of Disease

Current through Reg. 49, No. 28; July 12, 2024
(a) Respiratory
				  isolation of inmates.
(1) To prevent the
				  spread of
Mycobacterium tuberculosis
in the facility, it is
				  important to recognize and isolate inmates (in appropriate TB respiratory
				  isolation facilities) who have symptoms suggestive of TB disease. Officers and
				  health care staff shall suspect TB in inmates with a persistent cough (more
				  than two weeks duration), especially in the presence of other symptoms or signs
				  compatible with TB, such as weight loss, night sweats, bloody sputum, anorexia
				  or fever. These inmates shall be evaluated for TB no later than 72 hours after
				  observation or report of symptoms. The inmate shall not leave appropriate TB
				  respiratory isolation until TB is excluded or the inmate is on therapy and
				  documented to be noninfectious.
(2)
				  Inmates suspected of having TB shall be placed in respiratory isolation until
				  they are no longer infectious. Inmates who are cases or suspects shall be
				  released from isolation only after infectiousness has been ruled out. Three
				  consecutive negative sputum smears must be obtained before an inmate who has
				  had a positive smear can be considered noninfectious. At least two of the
				  sputum specimens shall be collected early in the morning of consecutive
				  days.
(3) Cough-inducing procedures
				  can place health staff and nearby inmates at special risk of acquiring TB
				  infection. These procedures include sputum collection, bronchoscopy, and the
				  administration of aerosolized pentamidine. It is very important to carry out
				  such procedures in an individual room or booth with negative pressure relative
				  to adjacent rooms and hallways, ideally with room or booth air exhausted
				  directly to the outside and away from all windows and air intake ducts. Inmates
				  should remain in the booth or treatment room and not return to common areas
				  until coughing has subsided.
(4)
				  The installation of ultraviolet (UV) lights may be considered in some
				  facilities, especially in high volume, high turnover holding facilities.
				  However, UV lights shall be used only to supplement other control measures
				  (such as good ventilation). Proper precautions and scheduled maintenance of the
				  lights are essential.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.178 - Reporting

Current through Reg. 49, No. 28; July 12, 2024
(a) Cases.
(1) All suspected or diagnosed cases of
				  tuberculosis (TB) shall be reported within one working day to the local health
				  authority or a Texas Department of Health regional office.
(2) The following information shall be
				  reported: complete name, date of birth, physical address and county of
				  residence, information on which diagnosis was based or suspected. In addition,
				  if known, radiographic or diagnostic imaging results and date(s); all
				  information necessary to complete the most recent versions of forms TB 400 A
				  & B (Report of Case and Patient Services), TB 340 (Report of Contacts) and
				  TB 341 (Continuation of Report of Contacts); laboratory results used to guide
				  prescribing, monitoring or modifying antibiotic treatment regimens for
				  tuberculosis to include, but not limited to, liver function studies, renal
				  function studies, and serum drug levels; pathology reports related to
				  diagnostic evaluations of tuberculosis; reports of imaging or radiographic
				  studies; records of hospital or outpatient care to include, but not limited to,
				  histories and physical examinations, discharge summaries and progress notes;
				  records of medication administration to include, but not limited to, directly
				  observed therapy (DOT) records, and drug toxicity and monitoring records; a
				  listing of other patient medications to evaluate the potential for drug-drug
				  interactions; and copies of court documents related to court ordered management
				  of tuberculosis. Reporting forms are available from local health departments,
				  Texas Department of Health regional offices, or the TB Elimination Division,
				  Texas Department of Health, 1100 West 49th Street, Austin, Texas,
				  78756.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.179 - Tuberculosis Record

Current through Reg. 49, No. 28; July 12, 2024
(a) Form and
				  content of the certificate. The certificate is part of a multipurpose form,
				  Tuberculosis Record, which shall be used for certification that an employee or
				  volunteer does not have tuberculosis; a medical record of the screening,
				  evaluation, and/or treatment of an employee or volunteer or an inmate; or as a
				  medical transfer record for employees, volunteers, or inmates moving from one
				  correctional facility to another. This form, or equivalent information, must
				  accompany an inmate whenever he or she is transferred from one correctional
				  facility to another.
(b) Deadline
				  for filing a certificate. The deadline for filing certificates is one month
				  after the certificate is completed and signed by a physician. The certificate
				  shall be filed with the local health authority.
(c) Tuberculosis record. The Tuberculosis
				  Record is a multipurpose report form that can be used for a Certificate, Record
				  of Transfer, and/or a Tuberculosis History Record. The form shall be used to
				  submit the reports pertaining to an employee, volunteer, or inmate of a jail or
				  correctional facility. The form to be used is as follows and is available from
				  the Texas Department of Health upon request.
Attached
					 Graphic
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.180 - Resource Allocation

Current through Reg. 49, No. 28; July 12, 2024
Under the terms of Chapter 786, §3, 73rd Legislature
					 (Act), the costs of providing inmate screening, evaluation, and treatment is
					 supported by a combination of individual counties and judicial districts, Texas
					 Department of Health (department), and Texas Department of Criminal Justice
					 (TDCJ) funds. The following terms govern this allocation.
(1) Texas Department of Health. The Texas
				  Department of Health (department) shall supply the materials, pharmaceuticals,
				  and laboratory services to covered jails and community corrections facilities
				  that are necessary to accomplish the screening required by the Act, and provide
				  other services requested by individual counties and judicial districts, where
				  such services can be reasonably provided. These materials, drugs, and services
				  may be requested from the Texas Department of Health, Tuberculosis Elimination
				  Division, 1100 West 49th Street, Austin, Texas 78756.
(2) Texas Department of Criminal Justice.
(A) The Texas Department of Criminal Justice
				  (TDCJ) shall provide funds for administering screenings, evaluating inmates,
				  and administering drugs to two classes of inmates suspected of having an active
				  case of tuberculosis. The two classes are:
(i) inmates whose paperwork and processing
				  required under Code of Criminal Procedure, 8, Subsection (a), Article 42.09,
				  has been completed; and
(ii)
				  inmates in a community corrections facility.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.190 - Approval of Local Jail Screening Standards

Current through Reg. 49, No. 28; July 12, 2024
(a) Counties, judicial districts, and private
				  entities operating community corrections facilities shall adopt local standards
				  for screening tests of employees, volunteers, and inmates.
(b) The standards required in subsection (a)
				  of this section shall, at minimum, be compatible with, and at least as
				  stringent as, the standards set out in these sections. In addition the
				  standards shall incorporate the requirements set out in the Texas Health and
				  Safety Code, §§
										89.001-89.072.
(c) Prior approval of the Texas Department of
				  Health (department) shall be obtained before the adoption of local jail
				  standards.
(d) Prior to final
				  adoption of local jail standards, the jail TB screening plan shall be submitted
				  to the Texas Department of Health, Tuberculosis Elimination Division, 1100 West
				  49th Street, Austin, Texas 78756-3199. The department shall review the jail TB
				  screening plans to determine their compliance with subsection (b) of this
				  section and the Texas Health and Safety Code, §
										89.073.
				  This approval shall be from the director of the Tuberculosis Elimination
				  Division. If the approval is denied by the director of the Tuberculosis
				  Elimination Division, the county, judicial district, or private entity may
				  appeal the denial to the Bureau Chief, Bureau of Communicable Disease Control,
				  Texas Department of Health, 1100 West 49th Street, Austin, Texas
				  78756.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter H - TUBERCULOSIS SCREENING FOR JAILS AND OTHER CORRECTIONAL FACILITIES › Section 97.191 - Continuity of Care

Current through Reg. 49, No. 28; July 12, 2024
A correctional facility regardless of size that houses
					 adult or youth inmates, must assure continuity of care for those inmates
					 receiving treatment for tuberculosis who are being released or transferred to
					 another correctional facility. A facility must contact the department prior to
					 the inmate being released or transferred, if possible. If that is not possible,
					 the facility must make the contact immediately upon the inmate's release from
					 custody or transfer to another correctional facility.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter I - IMMUNIZATION REQUIREMENTS FOR RESIDENTS OF TEXAS NURSING HOMES › Section 97.201 - Facilities Included in Requirements

Current through Reg. 49, No. 28; July 12, 2024
These requirements apply to nursing homes that are licensed
					 institutions serving residents who are elderly persons as defined by the Health
					 and Safety Code, §
										242.002.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter I - IMMUNIZATION REQUIREMENTS FOR RESIDENTS OF TEXAS NURSING HOMES › Section 97.202 - Required Immunizations

Current through Reg. 49, No. 28; July 12, 2024
(a)
				  Nursing homes are required to offer immunizations in accordance with the most
				  recent recommendations of the Advisory Committee on Immunization Practices
				  (ACIP).
(1) Pneumococcal vaccine for
				  residents. The facility must offer pneumococcal vaccination to all residents 65
				  years of age or older who have not received this immunization and to residents
				  younger than 65 years of age who have not received this vaccine but are
				  candidates for vaccination because of chronic illness. Pneumococcal vaccine
				  must be offered both to residents who currently reside in the facility and to
				  new residents upon admission. Vaccination must be completed unless the vaccine
				  is medically contraindicated by a physician or the resident refuses the
				  vaccine. Vaccine administration must be in accordance with the recommendations
				  of the Advisory Committee on Immunization Practices of the Centers for Disease
				  Control and Prevention at the time of the vaccination.
(2) Influenza vaccine for residents and
				  employees. The facility must offer influenza vaccination to residents and
				  employees in contact with residents. Vaccination must be completed unless the
				  vaccine is medically contraindicated by a physician or unless the employee or
				  resident has refused the vaccine.
(A)
				  Influenza vaccination for all residents and employees must be completed by
				  November 30 of each year. Employees hired or residents admitted after this date
				  and during the influenza season (through March of each year) must receive
				  influenza vaccinations unless medically contraindicated by a physician or
				  unless the employee or resident has refused the vaccine.
(B) Vaccine administration must be in
				  accordance with the recommendations of the Advisory Committee on Immunization
				  Practices of the Centers for Disease Control and Prevention at the time of the
				  most recent vaccination.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter K - RESPIRATORY SYNCYTIAL VIRUS › Section 97.251 - Definitions

Current through Reg. 49, No. 28; July 12, 2024
The following words and terms when used in this subchapter
					 and Health and Safety Code, Chapter 96 ("Respiratory Syncytial Virus") shall
					 have the following meanings unless the context clearly indicates
					 otherwise.
(1) Department--The
				  Department of State Health Services.
(2) Executive Commissioner--The Executive
				  Commissioner of the Health and Human Services Commission.
(3) Health facility includes:
(A) a general or special hospital licensed by
				  the department under Health and Safety Code, Chapter 241;
(B) a physician-owned or physician-operated
				  clinic;
(C) a publicly or privately
				  funded medical school;
(D) a state
				  hospital or state school maintained and managed by the Department of State
				  Health Services or the Department of Aging and Disability Services;
(E) a public health clinic conducted by a
				  local health unit, health department, or public health district organized and
				  recognized under Health and Safety Code, Chapter 121; and
(F) another facility specified by a rule
				  adopted by the executive commissioner.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter K - RESPIRATORY SYNCYTIAL VIRUS › Section 97.252 - Confidentiality

Current through Reg. 49, No. 28; July 12, 2024
(a) Except as
				  specifically authorized by this subchapter and Health and Safety Code, Chapter
				  96 ("Respiratory Syncytial Virus"), reports, records, and information furnished
				  to a department employee or to an authorized agent of the department that
				  relate to cases or suspected cases of a health condition are confidential and
				  may be used only for the purposes of this subchapter.
(b) Reports, records, and information
				  relating to cases or suspected cases of health conditions are not public
				  information under Government Code, Chapter 552, and may not be released or made
				  public on subpoena or otherwise except as provided by this chapter.
(c) The department may release medical,
				  epidemiological, or toxicological information:
(1) for statistical purposes, if released in
				  a manner that prevents the identification of any person;
(2) to medical personnel, appropriate state
				  agencies, health authorities, regional directors, and public officers of
				  counties and municipalities as necessary to comply with this subchapter and
				  Health and Safety Code, Chapter 96 ("Respiratory Syncytial Virus") relating to
				  the identification, monitoring, and referral of children with RSV; or
(3) to appropriate federal agencies, such as
				  the Centers for Disease Control and Prevention of the United States Public
				  Health Service.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter K - RESPIRATORY SYNCYTIAL VIRUS › Section 97.253 - Limitation of Liability

Current through Reg. 49, No. 28; July 12, 2024
A health professional, a health facility, or an
					 administrator, officer, or employee of a health facility subject to this
					 subchapter and Health and Safety Code, Chapter 96 ("Respiratory Syncytial
					 Virus") is not civilly or criminally liable for divulging information required
					 to be released under this subchapter and Health and Safety Code, Chapter 96
					 ("Respiratory Syncytial Virus"), except in a case of gross negligence or
					 willful misconduct.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter K - RESPIRATORY SYNCYTIAL VIRUS › Section 97.254 - Cooperation of Governmental Entities

Current through Reg. 49, No. 28; July 12, 2024
Another state board, commission, agency, or governmental
					 entity capable of assisting the department in carrying out the intent of this
					 subchapter and Health and Safety Code, Chapter 96 ("Respiratory Syncytial
					 Virus") shall cooperate with the department and furnish expertise, services,
					 and facilities to the sentinel surveillance program.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter K - RESPIRATORY SYNCYTIAL VIRUS › Section 97.255 - Sentinel Surveillance Program

Current through Reg. 49, No. 28; July 12, 2024
The department shall establish and maintain a sentinel
					 surveillance program for RSV infection in children. The program will:
(1) maintain a central database of
				  laboratory-confirmed cases of RSV that can be used to investigate the
				  incidence, prevalence, and trends of RSV; and
(2) recruit at least one health care facility
				  or provider associated with a health care facility in each Health Service
				  Region of the State to report RSV data.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter K - RESPIRATORY SYNCYTIAL VIRUS › Section 97.256 - Data Collection

Current through Reg. 49, No. 28; July 12, 2024
(a) To ensure
				  an accurate source of data, the department may require a health facility or
				  health professional to make available for review by the department or by an
				  authorized agent medical records or other information that is in the facility's
				  or professional's custody or control and that relates to an occurrence of
				  RSV.
(b) The department shall
				  request that data on RSV be reported weekly to the department through an
				  existing surveillance program as specified by the department.
(c) The data reported should include at
				  minimum the total number of laboratory tests performed for RSV infection and
				  the total number of positive tests for RSV infection collected during the week
				  for which it is reported.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 97 - COMMUNICABLE DISEASES › Subchapter K - RESPIRATORY SYNCYTIAL VIRUS › Section 97.257 - Database

Current through Reg. 49, No. 28; July 12, 2024
The department may use the data to:
(1) design and evaluate measures to prevent
				  the occurrence of RSV and other health conditions; and
(2) provide information and education to
				  providers on the incidence of RSV infection.
Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 98 - TEXAS HIV MEDICATION PROGRAM › Subchapter C - TEXAS HIV MEDICATION PROGRAM › Division 1 - GENERAL PROVISIONS › Section 98.101 - Purpose

Current through Reg. 49, No. 28; July 12, 2024
This subchapter establishes procedures and eligibility
						guidelines for programs under the Texas HIV Medication Program (THMP) as
						required in the Texas Health and Safety Code, §
											85.063.
(1) THMP operates in accordance with federal
					 AIDS Drug Assistance Program legislation to assist low-income individuals
					 living with HIV with direct medication assistance for medications on the
					 program formulary or costs associated with eligible health insurance policies,
					 including premiums and medication cost-sharing (deductibles, copayments, and
					 coinsurance) and Medicare prescription drug plans.
(2) Program enrollment and services are
					 subject to available funding.